期刊文献+

艾芬地尔重复鞘内注射对骨癌痛模型小鼠痛行为的影响 被引量:4

Effect of repeated intrathecal injection of ifenprodil on pain behaviors in mice with bone cancer pain
原文传递
导出
摘要 目的观察艾芬地尔重复鞘内注射对小鼠骨癌痛的影响。方法96只雄性C3H/HeJ小鼠随机分为肿瘤给药组(T组)、肿瘤对照组(c组)和假手术组(S组)。将含2×10^5个纤维肉瘤NCTC2472细胞的最小必需培养基(Ⅱ.MEM)注射到小鼠右侧股骨远端骨髓腔内,制作骨癌痛模型。假手术组注入不含肿瘤细胞的α-MEM。T组在术后第14天开始,鞘内注射艾芬地尔5μl(10μg),每天1次,连续3天。C组和s组在相同时间点分别给予相同体积的溶媒。各组于接种前1天,接种后第3天、第5天、第7天、第10天、第14天、第17天、第19天和第23天检测痛行为学指标,包括小鼠的自发抬足次数、机械性缩足反射阈值(PWMT)和热缩足反射潜伏期(PwTL)。按照分组在相应时间点处死小鼠,用Western-blotting方法检测脊髓腰膨大NR2B蛋白表达水平。结果肿瘤细胞接种后第14天,和s组及术前基础值相比,T组小鼠自发性抬足[(12.88±1.64)次]显著增加,PWMT(0.39±0.17)g和PWTL(11.59±1.67)S明显下降(P〈0.05)。脊髓NR2B蛋白(2.12±0.13)显著增加(P〈0.05)。肿瘤细胞接种后第17天,第19天,第23天,和第14天及C组相比,T组自发性抬足[(5.13±1.38)次,(4.70±1.58)次,(5.64±1.17)次]明显减少,PWMT[(1.10±0.65)g,(0.95±0.56)g,(1.05±0.26)g]和PWTL[(15.17±1.27)s,(15.93±2.18)s,(16.28±1.48)S]显著增加(P〈0.05)。脊髓NR2B蛋白[(1.42±0.17),(1.67±0.53),(1.14±0.79)]显著减少(P〈0.05)。结论重复鞘内注射艾芬地尔能显著改善骨癌痛小鼠的痛行为,降低脊髓NR2B蛋白。 Objective To investigate the effect of ifenprodil in the mice of bone cancer pain. Methods 96 male C3 H/HeJ mice were divided randomly into tumor group (Group T), control group (Group C ) and sham group( Group S). The a-minimal essence media (α-MEM) with 2 × 10^5 osteosarcoma NCTC 2472 cells were implanted into the intramedullary space of the right femurs of mice to induce ongoing bone cancer related pain behaviors. The sham group was inoculated by oL-MEM without any cells. On the 14th d after inoculation, pain ethol- ogy indexes such as the spontaneous lifting behaviors, the paw withdrawal mechanical threshold(PWMT) and the paw withdrawal thermal latency( PWTL) were observed on 1 d before inoculation and on 3 d,5 d,7 d, 10 d, 14 d, 17 d, 19 d ,23 d after inoculation. Lumbar intumescentia of mice in each group were taken out to investigate the expression level of NR2B western blot after pain behaviors tests at the same time point after intrathecal injection. Results (1) At dayl4 after the operation, the obvious increasing of spontaneous lifting behaviors (( 12.88 ±1.64 ) ) and the expression of N R2B (2.12 ± 0.13 ), the significant decreasing of PWMT ( (0.39 ±0.17 )g) and PWTL( (ll. 59 ± 1.67)s) were observed in group T compared with group S and preoperative base level(P〈 0.05 ). (2) At day 17 ,day 19 and day 23 after the operation,compared with the basal level of day14 before admin- istration and group C,the spontaneous lifting behaviors ( (5.13±1.38) , (4.70 ± 1.58) , (5.64 ± 1. 17) ) of group T were obviously decreased, PWMT ( ( 1. 10 ± 0.65 ) g, (0.95 ±0.56 ) g, ( 1.05 ± 0.26 ) g) and PWTL ((15.17±1.27)s,(15.93 ±2. 18)s,(16.28 ±1.48)s) were increased, the expression of NR2B((1.42 ± 0.17) ,(1.67 ±0.53) ,(1.14 ±0.79)) were significantly decreased(P〈0.05). Conclusion Repeated intrathca1 injection of ifenprodil can efficiently relieve spontaneous lifting behaviors, mechanical hyperalgia and thermal hyperalgia and decrease the expression of lumbar intumescentia NR2B in the mouse model of bone cancer pain.
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2012年第3期228-231,共4页 Chinese Journal of Behavioral Medicine and Brain Science
基金 国家自然基金资助项目(81070892,81171048) 江苏省自然基金资助项目(2009054) 江苏省六大人才高峰资助项目(2010105)
关键词 艾芬地尔 N-甲荃-D-天冬氨酸受体 骨癌痛 小鼠 Ifenprodil NR2B Bone cancer pain Mouse
  • 相关文献

参考文献13

  • 1Middlemiss T, Laird BJ, Fallon MT. Mechanisms of cancer-induced bone pain. Clin Oncol (R Coil Radiol) ,2011,23:387-392.
  • 2Gu X,Zhang J,Ma Z, et al. The role of N-methy-D-asparlate receptor subunit NR2B in spinal cord in cancer pain. Eur J Pain,2010,14: 496-502.
  • 3王俊华,张娟,周晓芳,马正良,夏小萍,高勤,梅凤梅,张睿.艾芬地尔鞘内注射对骨癌痛模型小鼠痛行为的改善作用[J].中华行为医学与脑科学杂志,2009,18(2):136-139. 被引量:11
  • 4Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganizaIon of the spinal cord in a murine model of bone cancer pain. J Neurosci, 1999,19 : 10886-10897.
  • 5Hylden JL, Wileox GL. Intrathecal morphine in mice:a new technique. Ear J Phrmacol, 1980,67:313-316.
  • 6Mantyh PW. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci,2006,7:797-809.
  • 7Honore P, Rogers SD, Schwei MJ, et al. Murine models of in ammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in spinal cord and sensory neurons. Neuroscience, 2000.98,585-598.
  • 8Gu X,Zhou X,Zheng Y,et al. Involvement of the spinal NMDA receptor/PKC gamma signaling pathway in the development of bone cancer pain. Brain Res,2010,1335:83-90.
  • 9Klein T, Magerl W, Hanschmann A, et al. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia. Eur J Pain ,2008,12 : 17-29.
  • 10刘成龙,马正良,梁樱,彭良玉,任炳旭,刘晓杰,顾小萍.鞘内注射钙/钙调蛋白依赖性蛋白激酶Ⅱ抑制剂KN93对骨癌痛小鼠痛行为的影响[J].中华行为医学与脑科学杂志,2010,19(10):867-869. 被引量:5

共引文献13

同被引文献58

  • 1马正良,夏小萍,朱巍,业光衡,韩鹂,费强.小鼠骨癌痛模型的建立及痛行为学和骨损害的观察[J].中国疼痛医学杂志,2007,13(5):288-292. 被引量:18
  • 2Rubens RD, Coleman RE. Bone metastases//Abeloff MD, ArmitageJO, Lichter AS,et al. Clinical oncology. New York: Churchill Living-stone ,1995 : 643 -665.
  • 3Honore P, Rogers SD,Schwei MJ,et al. Murine models of inflammato-ry ,neuropathic and cancer pain each generates a unique set of neuro-chemical change in the spinal cord and sensory neurons. Neuro-science ,2000,98 : 585 -598.
  • 4Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain.Part 1: clinical considerations. J Pain Symptom Manag, 2001,21:144-150.
  • 5Zuo Z. The role of opioid receptor internalization and beta-arrestins inthe development of opioid tolerance. Anesth Alalg, 2005 , 101:728-734.
  • 6Trang T,Quirion R,Jhamandas K. The spinal basis of opioid toleranceand physical dependence : involvement of calcitonin generedated pep-tide ,substance P,and arachidonie acid-derived metabolites. Peptides,2005,26:1346-1355.
  • 7Paley CA,Bennett MI,Johnson MI. Acupuncture for cancer-inducedbone pain? Evid Based Complement Altemat Med, 2011 , 2011 ;671043.
  • 8Huang QF. Exploration of clinical regularities in acupuncture-moxi-bustion treatment for cancer pain. J Acupunct Tuina Sci,2011,9:346-350.
  • 9王韵.神经肽II:阿片肽及其受体//韩济生.神经科学.3版.北京:北京大学医学出版社,2009:451.
  • 10Powell KJ,Ma W,Sutak M,et al. Blockade and reversal of spinal mor-phine tolerance by peptide and non-peptide calcitonin gene-relatedpeptide receptor antagonists. Br J Phamacol,2000,131:875-884.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部